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Abstracts / Biol Blood Marrow Transplant 21 (2015) S171eS184 S179were 13,6 ng/ml (range: 4,9-26,7 ng/ml) and 100% of the pa-
tients were in the insufﬁciency range levels (<30 ng/ml). Me-
dianPTHi levelswere62,6pg/ml (range:24,4-223,7pg/ml), and
46% of the patients had secondary hyperparathyroidism. In the
postHCTgroup,median25-OHvitaminD levelswere11,4ng/ml
(range: 4-29,4 ng/ml) and 100%had insuﬁciency levels.Median
PTHi levelswere 68pg/ml (range: 37,4-135,8pg/ml), and56%of
the patients had secondary hyperparathyroidism. 12 patients
had DXA before HCT and 3 (25%) of them had DXA lumbar Z
score less than -2.0. In 19 patients postHCT, 4 (21%) had
decreasedDXAZscore< 2.0.Nodifference couldbeestablished
between autologous or allogeneic HCT in any measurement.
Only the presence of chronic graft vs host disease (GVHD) was
associated with higher PTH levels by ANOVA test. None of the
other variables were associated with acute or chronic GVHD.
Conclusions: HCT patients represent a high-risk group of
developing severe vitamin D deﬁciency, secondary hyper-
parathyroidism and decreased DXA levels. These data are a
warning that this population of patients requires early inter-
vention toprevent long-termcomplications. This report is the
initial evaluation for the development and treatment of bone
health in a prospective matter in HCT patients in our center.228
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Leukemia relapses occurring in donor cells, so-called donor cell
leukemias (DCL) after allogeneic hematopoietic stem cell
transplantationhave been reported in several cases and still are
considered as rare diseases. Cytogenetic analysis, ﬂow cytom-
etryandmolecular testinghavebeenused to conﬁrm this event
in the cases so far reported. The incidence of this condition is
largelyunknown,aswellas the resultsof its treatment.Wehave
prospectively searched for DCL in a 12-year period, in a single
institution. In a group of 106 consecutive patients allografted
because of leukemia we have identiﬁed 7 cases of DCL; six of
themwere allografted because of relapsed acute lymphoblastic
leukemia (ALL) and one because of paroxysmal nocturnal he-
moglobinuria/aplastic anemia; these ﬁgures suggest that the
real incidence of DCL has been underestimated in previous
studies. All the patients were allografted from HLA-identical
siblings, employing a reduced-intensity conditioning regimen.
The cases appeared with median of 10 months after the allo-
graft; the number of blast cells when the leukemic activity
ensued was above 50% in all cases, whereas the chimerism
studies revealedmore than 90% cells of donor origin. The origin
of the leukemia cellswas shownbymicrosatellites andwith sex
mismatch. Six patients with lymphoblastic DCL were treated
prospectively with a pediatric-inspired combined chemo-
therapy schedule designed for “de novo” ALL patients. A com-
plete responsewas obtained in 3/6 patientswith lymphoblastic
DCL, these patients being alive in a complete remission at 11,12
and 98 months after the diagnosis of DCL. The long-term DCL
survivors remain full chimeras and did not need a second
transplant. It is concluded that the prevalence of DCL may behigher if it is prospectively looked for, and that acceptable
therapeutic results are obtained if patients are treated as “do
novo” leukemias employing combined chemotherapy.229
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Background: Quality of life (QOL) is an important consid-
eration in the counseling, implementation, and post
treatment management of arduous treatments for life-
threatening conditions, such as allogeneic hematopoietic cell
transplantation (allo-HCT).
Material and Methods: QOL was analyzed in leukemia pa-
tients who underwent allo-HCT using reduced intensity
conditioning (RIC) on an outpatient basis at either the Centro
de Hematología y Medicina Interna de Puebla of the Clínica
Ruiz or the Hematology Service of the Internal Medicine
Department of the Hospital “Dr. José Eleuterio González” of
the Universidad Autónoma de Nuevo León, and who had
survived above 12 months after the allograft, who could be
approached, who were in a continued complete remission-
with or without graft versus host disease and who were
willing to respond to the questionnaire. Thirty-ﬁve patients
fulﬁlling these requirements were included, and a sex and
age-matched group of 35 reference subjects was also studied.
Results: Allografted patients were found to have a slightly
better mental component summary than the reference sub-
jects (53.23 versus 48.66 points, p ¼ 0.01), whereas the
physical component summary did not show a difference
(54.53 versus 52.05 points, p ¼ 0.59). Most of the differences
between allografted individuals and reference subjects con-
trols were not signiﬁcant.
Conclusions: These data suggest that allografted individuals
employing our RIC regimen, enjoy a health-related quality of
life similar to that of reference subjects, adding, another
advantage of this method of conducting stem cell allograft-
ing. However, more work needs to be done to elucidate the
impact of RIC on QOL post-allo-HCT.230
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Background: Fatigue is a common side effect of chemo-
therapy, but is poorly studied in pediatric HSCT recipients.
Hope, or goal-directedness, may be impacted by fatigue. The
incidence and severity of fatigue and its impact on hope
warrants investigation.
Patients and Methods: Patients were eligible for enrollment
in this prospective study if they were between the ages of 5-
18 years. Patients unable to read English or otherwise unable
to complete the survey were ineligible. Subjects completed
the PedsQL Multidimensional Fatigue Scales(Fatigue QOL) and
Children’s Hope Scale. Subjects were enrolled during a regular
follow-up clinic visit and completed the survey. The results of
the fatigue surveys were then compared to healthy subjects
and oncology patients in a validated sample as reported by
Varni et al (Cancer, 2002; 94:2090-2106).
Results: Atotal of 25 subjectswhohadHSCTwere enrolled, at a
mean of 12 yrs. (range of 6-19 yrs). 2 had received autologous
HSCT, 23 had received allogeneic HSCT, and 1 patient received
an auto followed by an allo HSCT. 6 had GVHD at the time of
surveycompletion.HSCTrecipientshadanaverageTotal Fatigue
QOL score of 69.9 (range 38.9-95.8) and18/25 (72%) had a lower
score than the average for healthy subjects. HSCT recipients had
a statistically signiﬁcant lower average Total Fatigue QOL score
(69.9 vs. 80.5, p¼0.002) and average General Fatigue QOL score
(71.3 vs. 85.3, p¼0.002), and a trend to a lower average Sleep
FatigueQOL score (62.65vs. 75, p¼0.002),whencomparedwith
healthysubjects. Therewasnostatistically signiﬁcantdifference
in average Cognitive Fatigue QOL scores (73.98 vs. 81.14,
p¼0.63).There was no statistically signiﬁcant differences in
average FatigueQOL scores in SCTrecipientswhen compared to
patients undergoing chemotherapy. Proxy reports of fatigue
were higher than comparative populations. An analysis of fac-
tors failed to show any signiﬁcant impact on fatigue including
age, days post transplant, sex, TBI received, GVHD, mental
illness, ICU admission, and malnutrition-impacted fatigue or
hope. The average hope scorewas 0.76 (range of 0.46-1), which
corresponds to feeling hopeful “a lot of the time.” There was a
direct correlationbetweenTotal FatigueQOLandhopescores (r-
0.472, p¼0.02).
Conclusions: Fatigue is more prominent in pediatric HSCT
recipients than a control population. Fatigue is related to
hope. Fatigue experienced by HSCT recipients was similar to
that seen in children receiving chemotherapy. Proxy reports
of fatigueweremuch greater than those reported by both the
subject and compared to healthy and oncology proxy reports.
Larger prospective studies are needed to determine risk
factors for fatigue and to develop interventions to alleviate
fatigue in pediatric HSCT recipients.231
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Background: Children’s experience of stem cell trans-
plantation (SCT) is often marked with psychological distress
and poor quality of life. While coping with the exigencies of
life-threatening illness and treatment, children must also
deal with being conﬁned to a hospital isolation room for one
to several months.We hypothesized that there are numerous
evident stressors associated with being conﬁned to an
isolation roomwhile undergoing SCT that may contribute to
heightened anxiety and general psychological distress.
Methods: We aimed to identify stressors of pediatric SCT
isolation by interviewing members of a multidisciplinary pe-
diatric SCT care team. 33 participants represented all profes-
sional roles within the team, including physicians, nurses,
psychologists, social workers, child life specialists, chaplains,
school teachers, dieticians, occupational therapists, house-
keepers and clinical researchers. 20 semi-structured interviews
of 30-60 minutes each were conducted with members of the
same profession. The 11 interview questions pertained to the
isolation room, daily life in isolation, and distressing moments,
among others topics. Four researchers then performed an
inductive thematic analysis, developing a list of 13 codes, indi-
vidually coding interview excerpts, analyzing code application
frequencies and co-occurrences across professional groups, and
summarizing ﬁndings into themes.
Results: 4 main themes were identiﬁed: Lack of Control Over
their Life in the Hospital, Missing Out on the Rest of theWorld,
Changes in Social Relationships, and Disengagement from
Daily Life Activities. The most frequently applied codes were
also those with the highest co-occurrenceeConnectedness,
Family Involvement, Social Interaction, Control andMotivation.
Conclusion: From the collective perspective of a particular
pediatric SCT care team, children experience numerous
interrelated stressors associated with physical isolation
during SCT, as indicated by the 13 identiﬁed codes, and their
frequencies and co-occurrences across professional groups.
The four presented overarching themes can be targeted in
efforts to minimize patient anxiety and psychological
distress, potentially contributing to improved quality of life
and emotional well-being during hospitalization. To achieve
a more comprehensive understanding of patients’ emotional
needs from their clinical environments, this study must be
supplemented by patient and family perspectives of their
emotional experiences in isolation for SCT.232
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Background: Improved survival after allogeneic hematopoi-
etic cell transplantation (allo-HCT) enables us to learn more
about potential late complications after HCT, including meta-
bolic syndrome (MS). This is the ﬁrst study investigating the
prevalence or development of metabolic syndrome within the
ﬁrst year post-HCT in adultmyeloablative transplant recipients.
